The Japanese Ministry of Health, Labour and Welfare on Thursday approved BridgeBio Pharma, Inc. ( BBIO )‘s acoramidis, under the brand name Beyonttra, for adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM). Acoramidis is a selective small molecule, orally administered, near-complete (≥90%) transthyretin (TTR) stabilizer. ATTR-CM is a progressive, fatal disease that presents as an infiltrative, restrictive cardiomyopathy, resulting in heart failure. AstraZeneca Plc...

OTTAWA (Reuters) -Canada will wait until next week to respond to the latest U.S. threat of tariffs and nothing is off the table regarding possible countermeasures, Prime Minister Mark Carney said on Thursday. Carney told a press conference that he would speak to provincial premiers and business leaders on Friday to discuss a coordinated response to the auto sector tariffs...

Candel Therapeutics, Inc. ( CADL ) shares are are trading lower Thursday after the company released final survival data from its phase 2a clinical trial of CAN-2409. What To Know: The trial involved patients with stage III/IV non-small cell lung cancer (NSCLC) who had inadequate responses to immune checkpoint inhibitor (ICI) treatment. The median overall survival (mOS) was reported at...

NEW YORK, March 27 (Reuters) - Dua Lipa won the dismissal on Thursday of a lawsuit in Manhattan accusing the British pop star of copying her 2021 megahit Levitating from a 1979 disco song. U.S. District Judge Katherine Polk Failla said L. Russell Brown and Sandy Linzer failed to show substantial similarity between Levitating and their song Wiggle and Giggle...